Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma

Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma

Abstract Objective To evaluate the effects of the concomitant use of proton pump inhibitors (PPIs) and/or antibiotics (Abs) on oncological outcomes in patients with advanced urothelial carcinoma. Patients and methods We retrospectively evaluated 155 patients with advanced urothelial carcinoma who we...

Full description

Bibliographic Details
Main Authors: Yoshiharu Okuyama, Shingo Hatakeyama, Kazuyuki Numakura, Takuma Narita, Toshikazu Tanaka, Yuki Miura, Daichi Sasaki, Daisuke Noro, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Shintaro Narita, Takahiro Yoneyama, Yasuhiro Hashimoto, Tomonori Habuchi, Chikara Ohyama
Format: Article
Language:English
Published: Wiley 2022-03-01
Series:BJUI Compass
Subjects:
antibiotics
immune checkpoint inhibitors
immunotherapy
prognosis
proton pump inhibitor
urothelial carcinoma
Online Access:https://doi.org/10.1002/bco2.118

Internet

https://doi.org/10.1002/bco2.118

Similar Items